Bristol-Myers Squibb Company

BMY · Moat type: REGULIERUNG

MoatScore

10/10

Fair Value

143 USD

Margin of Safety

+57.8 %

Rating

STARK

GESCHÄFTSMODELL Bristol-Myers Squibb (BMY) is a global pharmaceutical manufacturer that generates revenues primarily through the development, marketing, and sale of prescription medications in the areas of oncology, hematology, immunology, and cardiology, whereby the moat is based on patent-protected blockbuster drugs and high regulatory approval barriers.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.